Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Voyageur Pharmaceuticals Ltd V.VM

Alternate Symbol(s):  VYYRF

Voyageur Pharmaceuticals Ltd. is a Canada-based company engaged in the development of barium and iodine Active Pharmaceutical Ingredients (API) and offers high-performance imaging contrast agents. The Company is focused on vertically integrating the barium and iodine contrast market, and aims at producing its own barium, iodine, and endo fullerenes. The Company’s products include SmoothX, SmoothHD, SmoothLD, VisionHD, VisionLD and V-Gas. SmoothX (2%w/v) is a contrast medium for use in computed tomography (CT) of the gastrointestinal tract. VisionHD is a high-density (98% w/w) barium powder suspension tailored for double-contrast radiographic examination of the gastrointestinal tract, esophagus, stomach and duodenum. It also owns a 100% interest in the Frances Creek barium sulfate (barite) project, which is a rare grade mineral suitable for the pharmaceutical marketplace that is intended to replace the current synthetic products with quality imaging products.


TSXV:VM - Post by User

Post by WarrantOfficeron May 29, 2024 8:24am
145 Views
Post# 36061862

PR vs Website

PR vs WebsiteVoyageur website states Vision HD 98%, Vision LD 96%, SmoothHD 105%, SmoothLD 60% can also be ordered. Yesterdays PR states that these 4 products are in their late stages of development......confusion....  If an entity wants to order the remaining four products, they are put on hold as the final development is not complete? IMO, not a good start to building a customer base, let alone a trusting relationship with perspective customers. I know it seems I am always picking fly pooh out of pepper, but...........

The PR does not state when the the first three years of commercialization should / could begin. There could be years of regulatory approval, as no guidance was shared. 

I'm throwing darts here but is this supposed to make everyone happy before the annual AGM in June?

On a positive note, this company does offer the sky as potential. Thats why I am here. 
<< Previous
Bullboard Posts
Next >>